Healthcare Realty Trust Incorpo (NYSE:HR).

Channing Capital Management, LLC sold 85,622 shares during the last quarter decreasing its stake in Healthcare Realty Trust Incorpo (HR) by 4.6%. Its stake stood at $61,036,000 an increase of 0.3% as of the end of the quarter.

Channing Capital Management, LLC isn’t the only one who has changed their investment in HR. As of the end of the quarter Sumitomo Mitsui Asset Management Company, Ltd had acquired 82,625 shares growing its stake by 24.3%. The value of the investment in Healthcare Realty Trust Incorpo went from $11,052,000 to $14,435,000 a change of $3,383,000 since the last quarter. Strs Ohio cut its position by selling 27,812 shares a decrease of 13.3% from 03/31/2017 to 06/30/2017. Strs Ohio now controls 181,662 shares valued at $6,203,000. The total value of its holdings decreased 8.9%.

As of quarter end Cubic Asset Management, LLC had sold a total of 675 shares trimming its holdings by 7.0%. The value of the investment in (HR) decreased from $315,000 to $308,000 decreasing 2.2% for the reporting period.

On June 15 the stock rating was downgraded to “Hold” from “” by analysts at Jefferies. On December 13 the company was rated “Outperform” according to a Wells Fargo report up from the previous “” rating.

On November 14 the stock rating was upgraded from “” to “Buy” by Cantor Fitzgerald. On November 4, 2016 the stock rating was set at “Market Perform” by JMP Securities which was a boost from the previous “Underperform” rating.

BTIG Research initiated coverage on the stock with a rating of “Neutral”. On June 22 the company was downgraded to “Underperform” from “” in an announcement from JMP Securities.

The company is down from yesterday’s close of $33.41. Additionally the company recently declared a dividend paid on Wednesday the 31st of May 2017. The dividend payment was $0.300 per share for the quarter which comes to $1.20 on an annualized basis. The dividend yield was $3.59. The ex-dividend date was Friday the 12th of May 2017.

Company chares are trading at $33.34 which is marginally under the 50 day moving average which is $34.27 and just above the 200 day moving average of $32.48. The 50 day moving average went down $-0.94 or -2.73% whereas the 200 day moving average was up $0.85 or +2.62%.

The P/E ratio is 34.68 and the market value is 3.88B. As of the last earnings report the EPS was $0.96 and is expected to be $0.62 for the current year with 116,512,000 shares outstanding. Next quarter’s EPS is estimated at $0.11 and the next full year EPS is anticipated to be $0.50.